NCT06156774|Recruiting
Loading search results
Sponsor study identifier
observational
130
1 country
21
Study Start
April 18, 2024
Actual (reported)Primary Completion
July 2026
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
July 2026
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
This is a multicenter prospective observational study lead by the FIL on sarcopenia and sGA as possible predictors of efficacy and toxicity outcomes in patients undergoing CAR-T cells treatment.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
July 2026
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
November 27, 2023
Actual (reported)December 5, 2023
Actual (reported)April 18, 2024
Actual (reported)July 2026
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
July 2026
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Best Overall Response Rates (ORR)
Best Overall Response Rates (ORR) after CAR-T therapy according to the presence or absence of sarcopenic status
up to 28 months
Best Complete Remission Rates (CRR)
up to 28 months
Progression-Free Survival (PFS)
up to 28 months
Overall Survival (OS)
up to 28 months
Incidence of CAR-T related toxicities
up to 28 months
Rate of admission to Intensive Care Units (ICU)
up to 28 months
Patients with B-cell non-Hodgkin Lymphoma scheduled to received CAR-T cell product according to Agenzia Italiana del Farmaco (AIFA) indications and technical data sheet of the drug
Patients will be treated with CAR-T cell product as per routine clinical practice.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Patients with B-cell non-Hodgkin Lymphoma scheduled to received CAR-T cell product according to Agenzia Italiana del Farmaco (AIFA) indications and technical data sheet of the drug
A.O. SS. Antonio e Biagio e Cesare Arrigo - S.C.D.U. Ematologia
Alessandria, Italy
AOU Ospedali Riuniti - Clinica di Ematologia
Ancona, Italy
Vittorio Ruggero Zilioli
ASST Grande Ospedale Metropolitano Niguarda
First Submitted
November 27, 2023
First Posted
December 5, 2023
Study Start
April 18, 2024
Actual (reported)Primary Completion
July 2026
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Allogeneic CD19 CAR-T Cells for the Treatment of Relapsed/Refractory B-cell Lymphoma
Contact the study team to confirm eligibility.
Azienda Ospedaliera S .Giuseppe Moscati - S.C. Ematologia e Trapianto emopoietico
Avellino, Italy
IRCCS Centro di Riferimento Oncologico di Aviano - Divisione di Oncologia e dei Tumori immuto-correlati
Aviano, Italy
ASST Spedali Civili di Brescia - S.C. Ematologia
Brescia, Italy
Ospedale di Castelfranco Veneto - Oncoematologia IOV
Castelfranco Veneto, Italy
Azienda Ospedaliera Universitaria Careggi - Unità funzionale di Ematologia
Florence, Italy
ASST Grande Ospedale Metropolitano Niguarda - S.C. Ematologia
Milan, Italy
Fondazione IRCCS Istituto Nazionale dei Tumori di Milano - Ematologia
Milan, Italy
Istituto Scientifico San Raffaele - Unità Linfomi - Dipartimento Oncoematologia
Milan, Italy
A.O. Ospedali Riuniti Villa Sofia-Cervello - Divisione di Ematologia
Palermo, Italy
Ospedale S. Maria della Misericordia - Ematologia
Perugia, Italy
Ospedale Guglielmo da Saliceto - U.O. Ematologia
Piacenza, Italy
AOU Pisana - U.O. Ematologia
Pisa, Italy
Azienda Unità Sanitaria Locale-IRCCS - Arcispedale Santa Maria Nuova - Ematologia
Reggio Emilia, Italy
Fondazione Policlinico Universitario A. Gemelli IRCCS - Università Cattolica S. Cuore - Ematologia
Roma, Italy
Policlinico Umberto I - Università "La Sapienza" - Istituto Ematologia -Dipartimento di Medicina Traslazionale e di Precisione
Roma, Italy
A.O.U. Citta della Salute e della Scienza di Torino - S.C. Ematologia
Torino, Italy
Azienda Sanitaria Universitaria Friuli Centrale (ASU FC) - Clinica di Ematologia
Udine, Italy
AOU Integrata di Verona - U.O. Ematologia
Verona, Italy
ULSS 8 Berica - Ospedale S. Bortolo - Ematologia
Vicenza, Italy
Study Completion
July 2026
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
December 8, 2025
Record last verified: 2025-12
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: